
Healthcare & Pharmaceuticals · BSE
Cian Healthcare Limited, incorporated in 2003, is a multinational manufacturing company certified by WHO-GMP and ISO 9001:2015, specializing in food supplements, sexual wellness, cosmeceuticals, nutraceuticals, ayurvedic, and pharmaceutical products. The company develops, manufactures, and commercializes products across 12 therapeutic divisions and 10 sales divisions, operating under its own brand while also engaging in government supplies, exports, and third-party manufacturing. Its product portfolio includes sachets, gels, lotions, creams, ointments, liquid orals, capsules, and tablets, and it holds a special license to manufacture veterinary products such as Venky's and SAVAvet. As of March 31, 2018, sales were comprised of 37% contract manufacturing, 24% government supplies, 23% franchise business, and 16% export sales.
Price Band
₹61 – ₹65
Issue Size
₹38.00 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹65
at current GMP
Subscribed
—
Open
2 May 2019
Close
15 May 2019
Allotment
20 May 2019
Refund
21 May 2019
Demat Credit
22 May 2019
Listing
23 May 2019
Designated Registrar: Bigshare Services Private Limited
Allotment Date
20 May 2019
Basis finalization
Refunds Initiate
21 May 2019
Mandate release
Demat Credit
22 May 2019
Shares in demat
Listing Debut
23 May 2019
Trading begins
Cian Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹38 Crores. The shares are offered at a price band of ₹61 to ₹65 per equity share on BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,30,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-05-22, while un-allotted funds or UPI block mandates will be released on 2019-05-21.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.